Journal Home > Volume 3 , Issue 3
Background:

The neuropeptide galanin has been shown to exhibit anticonvulsant effects in animal models. However, only a few studies have attempted to identify the galanin receptor subtype (s) involved in this effect. In the present study, the expression of galanin and that of its receptors in a rat model of temporal lobe epilepsy was studied to reveal the epileptogenesis-related alterations.

Methods:

Pilocarpine-inducted status epilepticus (SE) rat model was used for temporal lobe epilepsy. Galanin and galanin receptor mRNA was detected by Real-time polymerase chain reaction in dorsal hippocampus of rats at three different time points following SE: at the acute phase (24h), latent period (7 days), and chronic epileptic period (8 weeks). Using immunohistochemistry, galanin positive fibers and bodies were also observed.

Results:

In the acute seizure phase, a significant up-regulation of the galanin mRNA was observed in the hippocampus. Meanwhile, galanin-positive cells appeared, while galanin-positive fibers disappeared in the hilus of the dentate gyrus, stratum radiatum of CA1, and stratum lucidum of CA3, indicating an increase in galanin synthesis and release during the acute seizure phase. The gene expression analysis also indicated a significant increase in the transcription of galanin receptors GalR1 and GalR3 24h after SE. The increased levels of GalR1 mRNA were also observed in the latent and chronic epileptic periods.

Conclusion:

In general, these data suggest that adaptive changes occur in the galanin system during epileptogenesis that may affect its antiepileptic effects. Furthermore, these changes should be taken into account when attempting to pharmacologically modulate this system.


menu
Abstract
Full text
Outline
About this article

Increased expression of galanin and its receptors in the dorsal hippocampus during epileptogenesis in a rat model of pilocarpine-induced temporal lobe epilepsy

Show Author's information Jing Sun1,2Shu Xu2,3Xiaoxiao Li2Tianyi Li4Changqing Liu5Jian Zhou5Guoming Luan5Zhiqing Xu1,2( )
Department of Pathology, Capital Medical University, Beijing 100069, China
Department of Neurobiology, Beijing Key Laboratory of Neural Regeneration and Repair, Capital Medical University, Beijing 100069, China
Neurorehabilitation Center, Beijing Boai Hospital, China Rehabilitation Research Center, Beijing 100068, China
Laboratory of Translational Neuropharmacology, Department of Clinical Neuroscience, Center for Molecular Medicine L8:01, Karolinska University Hospital, Stockholm 17176, Sweden
Beijing Key Laboratory of Epilepsy, Sanbo Hospital, Capital Medical University, Beijing 100093, China

Abstract

Background:

The neuropeptide galanin has been shown to exhibit anticonvulsant effects in animal models. However, only a few studies have attempted to identify the galanin receptor subtype (s) involved in this effect. In the present study, the expression of galanin and that of its receptors in a rat model of temporal lobe epilepsy was studied to reveal the epileptogenesis-related alterations.

Methods:

Pilocarpine-inducted status epilepticus (SE) rat model was used for temporal lobe epilepsy. Galanin and galanin receptor mRNA was detected by Real-time polymerase chain reaction in dorsal hippocampus of rats at three different time points following SE: at the acute phase (24h), latent period (7 days), and chronic epileptic period (8 weeks). Using immunohistochemistry, galanin positive fibers and bodies were also observed.

Results:

In the acute seizure phase, a significant up-regulation of the galanin mRNA was observed in the hippocampus. Meanwhile, galanin-positive cells appeared, while galanin-positive fibers disappeared in the hilus of the dentate gyrus, stratum radiatum of CA1, and stratum lucidum of CA3, indicating an increase in galanin synthesis and release during the acute seizure phase. The gene expression analysis also indicated a significant increase in the transcription of galanin receptors GalR1 and GalR3 24h after SE. The increased levels of GalR1 mRNA were also observed in the latent and chronic epileptic periods.

Conclusion:

In general, these data suggest that adaptive changes occur in the galanin system during epileptogenesis that may affect its antiepileptic effects. Furthermore, these changes should be taken into account when attempting to pharmacologically modulate this system.

Keywords: hippocampus, epilepsy, antiepileptic, galanin, pilocarpine

References(43)

[1]
Falco-Walter, J. Epilepsy-Definition, Classification, Pathophysiology, and Epidemiology. Semin Neurol, 2020, 40(6): 617–623.
[2]
Tekgul, H., Simsek, E., Erdoğan, M. A., Yiğittürk, G., Erbaş, O., Taşkıran, D. The potential effects of anticonvulsant drugs on neuropeptides and neurotrophins in pentylenetetrazol kindled seizures in the rat. Int J Neurosci, 2020, 130(2): 193–203.
[3]
Sultana, B., Panzini, M. A., Veilleux Carpentier, A., Comtois, J., Rioux, B., Gore, G., Bauer, P. R., Kwon, C. S., Jetté, N., Josephson, C. B., Keezer, M. R. Incidence and Prevalence of Drug-Resistant Epilepsy: A Systematic Review and Meta-analysis. Neurology, 2021, 96(17): 805–817.
[4]
Löscher, W., Potschka, H., Sisodiy, a S. M., Vezzani, A. Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options. Pharmacol Rev, 2020, 72(3): 606–638.
[5]
Melander, T., Hokfelt, T., Rokaeus, A.Distribution of galaninlike immunoreactivity in the rat central nervous system. J Comp Neurol, 1986, 248(4): 475–517.
[6]
Skofitsch, G., Jacobowitz, D. M. Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides, 1985, 6(3): 509–546.
[7]
Branchek, T., Smith, K. E., Walker, M. W. Molecular biology and pharmacology of galanin receptors. Ann N Y Acad Sci, 1998, 863: 94–107.
[8]
Mazarati, A.M., Halaszi, E., Telegdy, G. Anticonvulsive effects of galanin administered into the central nervous system upon the picrotoxin-kindled seizure syndrome in rats. Brain Res, 1992, 589(1): 164–166.
[9]
Mazarati, A. M., Hohmann, J. G., Bacon, A., Liu, H., Sankar, R., Steiner, R. A., Wynick, D., Wasterlain, C. G. Modulation of hippocampal excitability and seizures by galanin. J Neurosci, 2000, 20(16): 6276–6281.
[10]
Kokaia, M., Holmberg, K., Nanobashvili, A., Xu, Z. Q., Kokaia, Z., Lendahl, U., Hilke, S., Theodorsson, E., Kahl, U., Bartfai, T., Lindvall, O., Hökfelt, T. Suppressed kindling epileptogenesis in mice with ectopic overexpression of galanin. Proc Natl Acad Sci U S A, 2001, 98(24): 14006–14011.
[11]
Schlifke, I., Kuteeva, E., Hokfelt, T., Kokaia, M. Galanin expressed in the excitatory fibers attenuates synaptic strength and generalized seizures in the piriform cortex of mice. Exp Neurol, 2006, 200(2): 398–406.
[12]
McColl, C. D., Jacoby, A. S., Shine, J., Iismaa, T. P., Bekkers, J. M. Galanin receptor-1 knockout mice exhibit spontaneous epilepsy, abnormal EEGs and altered inhibition in the hippocampus. Neuropharmacology, 2006, 50(2): 209–218.
[13]
Mazarati, A., Lu, X., Shinmei, S., Badie-Mahdavi, H., Bartfai, T. Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice. Neuroscience, 2004, 128(2): 431–441.
[14]
Mazarati, A., Lu, X., Kilk, K., Langel, U., Wasterlain, C., Bartfai, T. Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus. Eur J Neurosci, 2004, 19(12): 3235–3244.
[15]
Lu, X., Roberts, E., Xia, F., Sanchez-Alavez, M., Liu, T., Baldwin, R., Wu, S., Chang, J., Wasterlain, C. G., Bartfai, T. GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models. Proc Natl Acad Sci U S A, 2010, 107(34): 15229–15234.
[16]
Fetissov, S. O., Jacoby, A. S., Brumovsky,.PR., Shine,. J, Iismaa, T. P., Hökfelt, T. Altered hippocampal expression of neuropeptides in seizure-prone GALR1 knockout mice. Epilepsia, 2003, 44(8): 1022–1033.
[17]
Glien, M., Brandt, C., Potschka, H., Voigt, H., Ebert, U., Loscher, W. Repeated low-dose treatment of rats with pilocarpine: low mortality but high proportion of rats developing epilepsy. Epilepsy Res, 2001, 46(2): 111–119.
[18]
Racine, R. J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol, 1972, 32(3): 281–294.
[19]
Xu, Z. Q., Shi, T. J., Hökfelt, T. Galanin/GMAP- and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptors. J Comp Neurol, 1998, 392(2): 227–251.
DOI
[20]
Bruxel, E. M., Bruno, D. C. F., do Canto, A. M., Geraldis, J. C., Godoi, A. B., Martin, M., Lopes-Cendes, I. Multi-omics in mesial temporal lobe epilepsy with hippocampal sclerosis: Clues into the underlying mechanisms leading to disease. Seizure, 2021, 90: 34–50.
[21]
Morimoto, K., Fahnestock, M., Racine, R. J. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol, 2004, 73(1): 1–60.
[22]
Lin, E. J., Richichi, C., Young, D., Baer, K., Vezzani, A., During, M. J. Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development. Eur J Neurosci, 2003, 18(7): 2087–2092.
[23]
Haberman, R. P., Samulski, R. J., McCown, T. J. Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion. Nat Med, 2003, 9(8): 1076–1080.
[24]
McCown, T. J. Adeno-associated virus-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity in vivo. Mol Ther, 2006, 14(1): 63–68.
[25]
Kanter-Schlifke, I., Toft, S. A., Ledri, M., Kuteeva, E., Hokfelt, T., Kokaia, M. Galanin gene transfer curtails generalized seizures in kindled rats without altering hippocampal synaptic plasticity. Neuroscience, 2007, 150(4): 984–992.
[26]
Mazarati, A. M., Liu, H., Soomets, U., Sankar, R., Shin, D., Katsumori, H., Langel, U., Wasterlain, C. G. Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus. J Neurosci, 1998, 18(23): 10070–10077.
[27]
Wilson, D. N., Chung, H., Elliott, R. C., Bremer, E., George, D., Koh, S. Microarray analysis of postictal transcriptional regulation of neuropeptides. J Mol Neurosci, 2005, 25(3): 285–298.
[28]
Zini, S., Roisin, M.P., Langel, U., Bartfai, T., Ben-Ari, Y. Galanin reduces release of endogenous excitatory amino acids in the rat hippocampus. Eur J Pharmacol, 1993, 245(1): 1–7.
[29]
Xu, Z. Q., Ma, X., Soomets, U., Langel, U., Hökfelt, T. Electrophysiological evidence for a hyperpolarizing, galanin (1-15)-selective receptor on hippocampal CA3 pyramidal neurons. Proc Natl Acad Sci U S A, 1999, 96(25): 14583–14587.
[30]
Hökfelt, T., Wiesenfeld-Hallin, Z., Villar, M., Melander, T. Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripheral axotomy. Neurosci Lett, 1987, 83(3): 217–220.
[31]
Villar, M. J., Meister, B., Cortes, R., Schalling, M., Morris, M., Hokfelt, T. Neuropeptide gene expression in hypothalamic magnocellular neurons of normal and hypophysectomized rats: a combined immunohistochemical and in situ hybridization study. Neuroscience, 1990, 36(1): 181–199.
[32]
Cortes, R., Villar, M. J., Verhofstad, A., Hokfelt, T. Effects of central nervous system lesions on the expression of galanin: a comparative in situ hybridization and immunohistochemical study. Proc Natl Acad Sci U S A, 1990, 87(19): 7742–7746.
[33]
Li, Y., Mei, Z., Liu, S., Wang, T., Li, H., Li, X-X., Han, S., Yang, Y., Li, J., Xu, Z. Q. Galanin Protects from Caspase-8/12-initiated Neuronal Apoptosis in the Ischemic Mouse Brain via GalR1. Aging Dis, 2017, 8(1): 85–100.
[34]
Xu, Z. Q., Zheng, K., Hökfelt, T. Electrophysiological studies on galanin effects in brain-progress during the last six years. Neuropeptides, 2005, 39(3): 269–275.
[35]
Bai, Y. F., Ma, H.T., Liu, L. N., Li, H., Li, X. X., Yang, Y. T., Xue, B., Wang, D., Xu, Z. Q. D. Activation of galanin receptor 1 inhibits locus coeruleus neurons via GIRK channels. BiochemBiophys Res Commun, 2018, 503(1): 79–85.
[36]
Schauwecker, P.E. Galanin receptor 1 deletion exacerbates hippocampal neuronal loss after systemic kainate administration in mice. PLoS One, 2010, 5(12): e15657
[37]
Yang, Y., Li, Y., Liu, B., Li, C., Liu, Z., Deng, J., Luo, H., Li, X., Wu, J., Li, H., Wang, C.Y., Zhao, M., Wu, H., Lallemend, F., Svenningsson, P., Hökfelt, T. G. M., Xu,Z.Q.D.Involvement of Scratch2 in GalR1-mediated depression-like behaviors in the rat ventral periaqueductal gray. Proc Natl Acad Sci U S A, 2021, 118(24): e1922586118.
[38]
Kuteeva E., Hökfelt T., Wardi. T, Ogren S. O. Galanin, galanin receptor subtypes and depression-like behaviour. Exp Suppl, 2010, 102: 163–181.
[39]
Kim, A., Park, T. Diet-induced obesity regulates the galanin-mediated signaling cascade in the adipose tissue of mice. Mol Nutr Food Res, 2010, 54(9): 1361–1370.
[40]
Schmidhuber, S. M., Rauch, I., Kofler, B., Brain, S. D. Evidence that the modulatory effect of galanin on inflammatory edema formation is mediated by the galanin receptor 3 in the murine microvasculature. J Mol Neurosci, 2009, 37(2): 177–181.
[41]
Belfer, I., Hipp, H., Bollettino, A., McKnight, C., Evans, C., Virkkunen, M., Albaugh, B., Max, M. B., Goldman, D., Enoch, M. A. Alcoholism is associated with GALR3 but not two other galanin receptor genes. Genes Brain Behav, 2007, 6(5): 473–481.
[42]
Swanson, C. J., Blackburn, T. P., Zhang, X., Zheng, K., Xu, Z. Q., Hökfelt, T., Wolinsky, T. D., Konkel, M. J., Chen, H., Zhong, H., Walker, M. M., Durkin, M., Artymyshyn, R. P., Smith, K. E., Jones, K. J., Craig, D. A., Gerald, C. P., Brancheck, T. A. Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299. Proc Natl Acad Sci U S A, 2005, 102(48): 17489–17494.
[43]
Lu, X., Mazarati, A., Sanna, P., Shinmei, S., Bartfai, T. Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity. Neuropeptides, 2005, 39(3): 147–152.
Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 08 August 2022
Revised: 13 October 2023
Accepted: 13 October 2023
Published: 05 November 2023
Issue date: November 2023

Copyright

© The Author(s) 2023

Acknowledgements

Not applicable.

Rights and permissions

Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attributtion-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission.

Return